Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2016 | 1 |
2017 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Viral Delivery of IL-7 Is a Potent Immunotherapy Stimulating Innate and Adaptive Immunity and Confers Survival in Sepsis Models.
J Immunol. 2022 Jul 1;209(1):99-117. doi: 10.4049/jimmunol.2101145. Epub 2022 Jun 6.
J Immunol. 2022.
PMID: 35667841
Intravenous injection of a novel viral immunotherapy encoding human interleukin-7 in nonhuman primates is safe and increases absolute lymphocyte count.
Coupet CA, Dubois C, Evlachev A, Kehrer N, Baldazza M, Hofman S, Vierboom M, Martin P, Inchauspe G.
Coupet CA, et al. Among authors: kehrer n.
Hum Vaccin Immunother. 2022 Nov 30;18(6):2133914. doi: 10.1080/21645515.2022.2133914. Epub 2022 Oct 31.
Hum Vaccin Immunother. 2022.
PMID: 36315906
Free PMC article.
Item in Clipboard
IL-7 producing immunotherapy improves ex vivo T cell functions of immunosenescent patients, especially post hip fracture.
Marton C, Minaud A, Coupet CA, Chauvin M, Dhiab J, Vallet H, Boddaert J, Kehrer N, Bastien B, Inchauspe G, Barraud L, Sauce D.
Marton C, et al. Among authors: kehrer n.
Hum Vaccin Immunother. 2023 Aug 1;19(2):2232247. doi: 10.1080/21645515.2023.2232247.
Hum Vaccin Immunother. 2023.
PMID: 37417353
Free PMC article.
Item in Clipboard
Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042.
Accart N, Urosevic-Maiwald M, Dummer R, Bataille V, Kehrer N, Niculescu C, Limacher JM, Chenard MP, Bonnefoy JY, Rooke R.
Accart N, et al. Among authors: kehrer n.
J Transl Med. 2013 Sep 25;11:226. doi: 10.1186/1479-5876-11-226.
J Transl Med. 2013.
PMID: 24063735
Free PMC article.
Clinical Trial.
Item in Clipboard
Sequential administration of a MVA-based MUC1 cancer vaccine and the TLR9 ligand Litenimod (Li28) improves local immune defense against tumors.
Schaedler E, Remy-Ziller C, Hortelano J, Kehrer N, Claudepierre MC, Gatard T, Jakobs C, Préville X, Carpentier AF, Rittner K.
Schaedler E, et al. Among authors: kehrer n.
Vaccine. 2017 Jan 23;35(4):577-585. doi: 10.1016/j.vaccine.2016.12.020. Epub 2016 Dec 21.
Vaccine. 2017.
PMID: 28012777
Item in Clipboard
Cite
Cite